환자 지원 기술 시장 규모, 점유율, 동향 분석 리포트 : 유형별, 지역별, 부문 예측(2024-2030년)

Patient Support Technology Market Growth & Trends:

The global patient support technology market is expected to reach USD 3.2 billion by 2030, registering a CAGR of 10.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing requirement for comprehensive patient-centric solutions, increasing adoption of digital healthcare solutions by healthcare systems, technological advancements, and active participation in strategic advancements by the market players are expected to drive market growth.

Furthermore, mobile health applications or mHealth apps are playing a crucial role in accelerating the growth of the patient support technology market. These applications provide diverse functionalities, including medication reminders, health monitoring, symptom tracking, and virtual consultations. They encourage patients by enabling active engagement in their healthcare management, promoting healthy habits, and facilitating seamless communication with healthcare providers. The rising use of smartphones and wearable devices amplifies the adoption of mHealth apps, solidifying their position as an essential component of the patient support technology ecosystem.

According to IQVIA, companies seeking optimal outcomes for stakeholders should align their investment strategy in Patient Support Program (PSP) technology with the EESI (EASY) goals. These objectives emphasize enhancing patient and care partner engagement, fostering collaboration among service teams, simplifying user experiences, and enhancing insight generation for improved patient outcomes. This alignment involves promoting active participation, effective communication, and shared decision-making among patients and their care partners, facilitating seamless teamwork and communication across service teams, designing intuitive interfaces for enhanced usability, and leveraging data-driven approaches to derive actionable insights and streamline workflows. By integrating their PSP technology investment strategy with the EESI (EASY) goals, companies can elevate patient engagement, enhance team collaboration, streamline user experiences, and drive better patient outcomes.

Furthermore, technology offers the potential to enhance program performance measurement, enabling the incorporation of practical assessments into patient outcomes. This technology is utilized to conduct thorough investigations into longitudinal performance, aiding in evaluating patient outcomes during therapy over extended periods. Furthermore, AI and machine learning-driven technology platforms analyze patients' diverse needs, enabling a more customized and personalized experience. Integrating innovative technologies across different stages of the patient support lifecycle presents an opportunity to gain comprehensive insights into patient needs through data and advanced analytics.

In September 2023, Microsoft Corp. and Mercy partnered to utilize generative AI and digital technologies, enabling healthcare providers to devote more time to patient care and enhance the patient experience. Generative AI-assisted communication empowers patients by providing understandable lab results and facilitating informed discussions. Additionally, the chatbot aids Mercy co-workers in swiftly accessing essential information, allowing nurses and staff to focus more on patient care.

Patient Support Technology Market Report Highlights:

• Based on type, the integrated segment dominated the market in 2023, owing to the availability of a comprehensive solution and increased focus on patient-centered care.
• North America dominated the global market with a revenue share of 41.12% in 2023. The growth is attributed to the increasing government initiative, technological advancement in the healthcare industry, and a strong presence of key market players.
• The patient support technology market is competitive, and various players are adopting strategies such as new product launches, partnerships, and acquisitions to strengthen their market share. For instance, in October 2023, ZS launched the AI-powered ZAIDYN Connected Health solution, part of the ZAIDYN by ZS platform. ZAIDYN Connected Health helps pharmaceutical companies, healthcare providers, and payers innovate to understand unmet needs, better engage with patients, and improve health outcomes.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Type
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline.
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database.
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Patient Support Technology Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Patient Support Technology Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & legal landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social & environmental landscape
    • 3.3.2.4. Technological landscape
  • 3.3.3. Impact of COVID-19

Chapter 4. Patient Support Technology Market: Type Estimates & Trend Analysis

• 4.1. Type Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Patient Support Technology Market by Type Outlook
• 4.4. Standalone
  • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.5. Integrated
  • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Patient Support Technology Market: Regional Estimates & Trend Analysis, By Type

• 5.1. Regional Market Share Analysis, 2023 & 2030
• 5.2. Regional Market Dashboard
• 5.3. Global Regional Market Snapshot
• 5.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
• 5.5. North America
  • 5.5.1. U.S.
    • 5.5.1.1. Key country dynamics
    • 5.5.1.2. Regulatory framework/ reimbursement structure
    • 5.5.1.3. Competitive scenario
    • 5.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5.2. Canada
    • 5.5.2.1. Key country dynamics
    • 5.5.2.2. Regulatory framework/ reimbursement structure
    • 5.5.2.3. Competitive scenario
    • 5.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Europe
  • 5.6.1. UK
    • 5.6.1.1. Key country dynamics
    • 5.6.1.2. Regulatory framework/ reimbursement structure
    • 5.6.1.3. Competitive scenario
    • 5.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6.2. Germany
    • 5.6.2.1. Key country dynamics
    • 5.6.2.2. Regulatory framework/ reimbursement structure
    • 5.6.2.3. Competitive scenario
    • 5.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6.3. France
    • 5.6.3.1. Key country dynamics
    • 5.6.3.2. Regulatory framework/ reimbursement structure
    • 5.6.3.3. Competitive scenario
    • 5.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6.4. Italy
    • 5.6.4.1. Key country dynamics
    • 5.6.4.2. Regulatory framework/ reimbursement structure
    • 5.6.4.3. Competitive scenario
    • 5.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6.5. Spain
    • 5.6.5.1. Key country dynamics
    • 5.6.5.2. Regulatory framework/ reimbursement structure
    • 5.6.5.3. Competitive scenario
    • 5.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6.6. Denmark
    • 5.6.6.1. Key country dynamics
    • 5.6.6.2. Regulatory framework/ reimbursement structure
    • 5.6.6.3. Competitive scenario
    • 5.6.6.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6.7. Sweden
    • 5.6.7.1. Key country dynamics
    • 5.6.7.2. Regulatory framework/ reimbursement structure
    • 5.6.7.3. Competitive scenario
    • 5.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6.8. Norway
    • 5.6.8.1. Key country dynamics
    • 5.6.8.2. Regulatory framework/ reimbursement structure
    • 5.6.8.3. Competitive scenario
    • 5.6.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Asia Pacific
  • 5.7.1. Japan
    • 5.7.1.1. Key country dynamics
    • 5.7.1.2. Regulatory framework/ reimbursement structure
    • 5.7.1.3. Competitive scenario
    • 5.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7.2. China
    • 5.7.2.1. Key country dynamics
    • 5.7.2.2. Regulatory framework/ reimbursement structure
    • 5.7.2.3. Competitive scenario
    • 5.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7.3. India
    • 5.7.3.1. Key country dynamics
    • 5.7.3.2. Regulatory framework/ reimbursement structure
    • 5.7.3.3. Competitive scenario
    • 5.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7.4. Australia
    • 5.7.4.1. Key country dynamics
    • 5.7.4.2. Regulatory framework/ reimbursement structure
    • 5.7.4.3. Competitive scenario
    • 5.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7.5. South Korea
    • 5.7.5.1. Key country dynamics
    • 5.7.5.2. Regulatory framework/ reimbursement structure
    • 5.7.5.3. Competitive scenario
    • 5.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7.6. Thailand
    • 5.7.6.1. Key country dynamics
    • 5.7.6.2. Regulatory framework/ reimbursement structure
    • 5.7.6.3. Competitive scenario
    • 5.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
• 5.8. Latin America
  • 5.8.1. Brazil
    • 5.8.1.1. Key country dynamics
    • 5.8.1.2. Regulatory framework/ reimbursement structure
    • 5.8.1.3. Competitive scenario
    • 5.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8.2. Mexico
    • 5.8.2.1. Key country dynamics
    • 5.8.2.2. Regulatory framework/ reimbursement structure
    • 5.8.2.3. Competitive scenario
    • 5.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8.3. Argentina
    • 5.8.3.1. Key country dynamics
    • 5.8.3.2. Regulatory framework/ reimbursement structure
    • 5.8.3.3. Competitive scenario
    • 5.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 5.9. MEA
  • 5.9.1. South Africa
    • 5.9.1.1. Key country dynamics
    • 5.9.1.2. Regulatory framework/ reimbursement structure
    • 5.9.1.3. Competitive scenario
    • 5.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9.2. Saudi Arabia
    • 5.9.2.1. Key country dynamics
    • 5.9.2.2. Regulatory framework/ reimbursement structure
    • 5.9.2.3. Competitive scenario
    • 5.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9.3. UAE
    • 5.9.3.1. Key country dynamics
    • 5.9.3.2. Regulatory framework/ reimbursement structure
    • 5.9.3.3. Competitive scenario
    • 5.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9.4. Kuwait
    • 5.9.4.1. Key country dynamics
    • 5.9.4.2. Regulatory framework/ reimbursement structure
    • 5.9.4.3. Competitive scenario
    • 5.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Recent Developments & Impact Analysis, By Key Market Participants
• 6.2. Company/Competition Categorization
  • 6.2.1. Innovators
  • 6.2.2. List of key distributors and channel partners
  • 6.2.3. Key customers
  • 6.2.4. Key company market share analysis, 2023
  • 6.2.5. Deloitte
    • 6.2.5.1. Company overview
    • 6.2.5.2. Financial performance
    • 6.2.5.3. Product benchmarking
    • 6.2.5.4. Strategic initiatives
  • 6.2.6. Accenture
    • 6.2.6.1. Company overview
    • 6.2.6.2. Financial performance
    • 6.2.6.3. Product benchmarking
    • 6.2.6.4. Strategic initiatives
  • 6.2.7. McKesson Corporation
    • 6.2.7.1. Company overview
    • 6.2.7.2. Financial performance
    • 6.2.7.3. Product benchmarking
    • 6.2.7.4. Strategic initiatives
  • 6.2.8. Cardinal Health
    • 6.2.8.1. Company overview
    • 6.2.8.2. Financial performance
    • 6.2.8.3. Product benchmarking
    • 6.2.8.4. Strategic initiatives
  • 6.2.9. DataRiver S.r.l
    • 6.2.9.1. Company overview
    • 6.2.9.2. Financial performance
    • 6.2.9.3. Product benchmarking
    • 6.2.9.4. Strategic initiatives
  • 6.2.10. Medisafe
    • 6.2.10.1. Company overview
    • 6.2.10.2. Financial performance
    • 6.2.10.3. Product benchmarking
    • 6.2.10.4. Strategic initiatives
  • 6.2.11. Inizio Engage
    • 6.2.11.1. Company overview
    • 6.2.11.2. Financial performance
    • 6.2.11.3. Product benchmarking
    • 6.2.11.4. Strategic initiatives
  • 6.2.12. AssistRx
    • 6.2.12.1. Company overview
    • 6.2.12.2. Financial performance
    • 6.2.12.3. Product benchmarking
    • 6.2.12.4. Strategic initiatives